{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:20:15Z","timestamp":1776064815114,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T00:00:00Z","timestamp":1496707200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"FIPE-HCPA","award":["15-0136"],"award-info":[{"award-number":["15-0136"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10067-017-3714-6","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T02:49:45Z","timestamp":1496717385000},"page":"1891-1896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents"],"prefix":"10.1007","volume":"36","author":[{"given":"Giovana","family":"Garziera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Luis Bittencourt","family":"Morsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Otesbelgue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Luiza","family":"Staub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pen\u00e9lope Esther","family":"Palominos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claiton Viegas","family":"Brenol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Rossato","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"key":"3714_CR1","unstructured":"Secretaria de Vigil\u00e2ncia em Sa\u00fade - Minist\u00e9rio da Sa\u00fade. Boletim Epidemiol\u00f3gico. 2016. Available at: www.saude.gov.br"},{"key":"3714_CR2","unstructured":"World Health Organization. Global tuberculosis report. 2016. Available at: www.who.int"},{"key":"3714_CR3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","volume":"33","author":"U Mack","year":"2009","unstructured":"Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D et al (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33:956\u2013973","journal-title":"Eur Respir J"},{"key":"3714_CR4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2169\/internalmedicine.53.1936","volume":"53","author":"T Ishiguro","year":"2014","unstructured":"Ishiguro T, Takayanagi N, Kagiyama N, Yanagisawa T, Sugita Y (2014) Characteristics of tuberculosis in patients with rheumatoid arthritis: a retrospective single-center study. Intern med 53:1291\u20131298","journal-title":"Intern med"},{"key":"3714_CR5","first-page":"193","volume":"8","author":"KM Alawneh","year":"2014","unstructured":"Alawneh KM, Ayesh MH, Khassawneh BY, Saadeh SS, Smadi M, Bashaireh K (2014) Anti-TNF therapy in Jordan: a focus on severe infections and tuberculosis. Biologics 8:193\u2013198","journal-title":"Biologics"},{"key":"3714_CR6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jbspin.2010.12.004","volume":"78","author":"L Baronnet","year":"2011","unstructured":"Baronnet L, Barnetche T, Kahn V, Lacoin C, Richez C, Schaeverbeke T (2011) Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review. Joint Bone Spine 78:279\u2013284","journal-title":"Joint Bone Spine"},{"key":"3714_CR7","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/annrheumdis-2013-204960","volume":"74","author":"EV Arkema","year":"2015","unstructured":"Arkema EV, Jonsson J, Baecklund E, Bruchfeld J, Feltelius N, Askling J (2015) Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments? Ann Rheum dis 74:1212\u20131217","journal-title":"Ann Rheum dis"},{"key":"3714_CR8","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","volume":"52","author":"J Askling","year":"2005","unstructured":"Askling J, Fored M, Brandt L, Baecklund E, Bertilisson L (2005) Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 52:1986\u20131992","journal-title":"Arthritis Rheum"},{"key":"3714_CR9","first-page":"1436","volume":"30","author":"L Carmona","year":"2003","unstructured":"Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I et al (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30:1436\u20131439","journal-title":"J Rheumatol"},{"key":"3714_CR10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/1756-185X.12375","volume":"17","author":"R Scrivo","year":"2014","unstructured":"Scrivo R, Armignacco O (2014) Tuberculosis risk and anti-tumour necrosis factor agents in rheumatoid arthritis: a critical appraisal of national registry data. Int J Rheum dis 17:716\u2013724","journal-title":"Int J Rheum dis"},{"key":"3714_CR11","first-page":"706","volume":"34","author":"SS Seong","year":"2007","unstructured":"Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS et al (2007) Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 34:706\u2013711","journal-title":"J Rheumatol"},{"key":"3714_CR12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care res (Hoboken ) 64:625\u2013639","journal-title":"Arthritis Care res (Hoboken )"},{"key":"3714_CR13","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","volume":"64","author":"LD Ponce de","year":"2005","unstructured":"Ponce de LD, Acevedo-Vasquez E, Sanchez-Torres A, Cucho M, Alfaro J, Perich R et al (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum dis 64:1360\u20131361","journal-title":"Ann Rheum dis"},{"key":"3714_CR14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1590\/S1806-37132009001000011","volume":"35","author":"MB Conde","year":"2009","unstructured":"Conde MB, Melo FA, Marques AM et al (2009) III Brazilian thoracic association guidelines on tuberculosis. J Bras Pneumol 35:1018\u20131048","journal-title":"J Bras Pneumol"},{"key":"3714_CR15","unstructured":"Minist\u00e9rio da Sa\u00fade. Programa Nacional de Controle da Tuberculose 2011. Available at: www.saude.gov.br"},{"key":"3714_CR16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1590\/S0482-50042011000100004","volume":"51","author":"MR Callado","year":"2011","unstructured":"Callado MR, Lima JR, Nobre CA, Vieira WP (2011) Low prevalence of reactive PPD prior to infliximab use: comparative study on a population sample of Hospital Geral de Fortaleza. Rev Bras Reumatol 51:40\u201352","journal-title":"Rev Bras Reumatol"},{"key":"3714_CR17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.5588\/ijtld.13.0755","volume":"18","author":"KR Bonfiglioli","year":"2014","unstructured":"Bonfiglioli KR, Ribeiro AC, Moraes JC, Saad CG, Souza FH, Calich AL et al (2014) LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area. Int J Tuberc Lung dis 18:905\u2013911","journal-title":"Int J Tuberc Lung dis"},{"key":"3714_CR18","doi-asserted-by":"crossref","first-page":"430134","DOI":"10.1155\/2014\/430134","volume":"2014","author":"S Agarwal","year":"2014","unstructured":"Agarwal S, Das SK, Agarwal GG, Srivastava R (2014) Steroids decrease prevalence of positive tuberculin skin test in rheumatoid arthritis: implications on anti-TNF therapies. Interdiscip Perspect Infect dis 2014:430134","journal-title":"Interdiscip Perspect Infect dis"},{"key":"3714_CR19","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.5588\/ijtld.12.0111","volume":"16","author":"N Saidenberg-Kermanac'h","year":"2012","unstructured":"Saidenberg-Kermanac'h N, Semerano L, Naccache JM, Brauner M, Falgarone G, Dumont-Fischer D et al (2012) Screening for latent tuberculosis in anti-TNF-alpha candidate patients in a high tuberculosis incidence setting. Int J Tuberc Lung dis 16:1307\u20131314","journal-title":"Int J Tuberc Lung dis"},{"key":"3714_CR20","first-page":"346","volume":"66","author":"F Bartalesi","year":"2013","unstructured":"Bartalesi F, Goletti D, Spinicci M, Cavallo A, Attala L, Mencarini J et al (2013) Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment. J Inf Secur 66:346\u2013356","journal-title":"J Inf Secur"},{"key":"3714_CR21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/ard.43.3.430","volume":"43","author":"P Emery","year":"1984","unstructured":"Emery P, Panayi G, Symmons D, Brown G (1984) Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: the role of protein energy malnutrition. Ann Rheum dis 43:430\u2013434","journal-title":"Ann Rheum dis"},{"key":"3714_CR22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.semarthrit.2012.07.001","volume":"42","author":"JH Kim","year":"2013","unstructured":"Kim JH, Cho SK, Han M, Choi CB, Kim TH, Jun JB et al (2013) Factors influencing discrepancies between the QuantiFERON-TB gold in tube test and the tuberculin skin test in Korean patients with rheumatic diseases. Semin Arthritis Rheum 42:424\u2013432","journal-title":"Semin Arthritis Rheum"},{"key":"3714_CR23","first-page":"179","volume":"63","author":"IM Laurindo","year":"2004","unstructured":"Laurindo IM, Seiscento M (2004) Bombardia Sea (Eds): diagnosis of latent tuberculosis in rheumatoid arthritis (RA) patients: tuberculin test (PPD) assessment. Ann Rheum dis 63:179","journal-title":"Ann Rheum dis"},{"key":"3714_CR24","first-page":"433","volume":"8","author":"L Paimela","year":"1990","unstructured":"Paimela L, Johansson-Stephansson EA, Koskimies S, Leirisalo-Repo M (1990) Depressed cutaneous cell-mediated immunity in early rheumatoid arthritis. Clin Exp Rheumatol 8:433\u2013437","journal-title":"Clin Exp Rheumatol"},{"key":"3714_CR25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0889-857X(05)70204-0","volume":"27","author":"GS Panayi","year":"2001","unstructured":"Panayi GS, Corrigall VM (2001) Pitzalis C: pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. Rheum dis Clin N am 27:317\u2013334","journal-title":"Rheum dis Clin N am"},{"key":"3714_CR26","first-page":"54","volume":"25","author":"IH Koker","year":"2007","unstructured":"Koker IH, Pamuk ON, Karlikaya C, Tuncbilek N, Cakir N (2007) A low prevalance of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT findings. Clin Exp Rheumatol 25:54\u201359","journal-title":"Clin Exp Rheumatol"},{"key":"3714_CR27","first-page":"121","volume":"49","author":"CDL Marques","year":"2009","unstructured":"Marques CDL, Duarte ALBP, Lorena VMB, Souza JR, Souza W, Gomes YM et al (2009) Resposta atenuada ao PPD no diagn\u00f3stico de infec\u00e7\u00e3o tuberculosa latente em pacientes com artrite reumat\u00f3ide. Rev Bras Reumatol 49:121\u2013125","journal-title":"Rev Bras Reumatol"},{"key":"3714_CR28","unstructured":"WHO-UNICEF. Estimates of BCG coverage (1980\u20132008). Available at: www.who.int\/immunization_monitoring\/en\/globalsummary\/timeseries\/tswucoveragebg.htm"},{"key":"3714_CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10067-008-1007-9","volume":"28","author":"I Fuchs","year":"2009","unstructured":"Fuchs I, Avnon L, Freud T, Abu-Shakra M (2009) Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors. Clin Rheumatol 28:167\u2013172","journal-title":"Clin Rheumatol"},{"key":"3714_CR30","first-page":"1401","volume":"12","author":"PC Chan","year":"2008","unstructured":"Chan PC, Chang LY, Wu YC, Lu CY, Kuo HS, Lee CY et al (2008) Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children. Int J Tuberc Lung dis 12:1401\u20131406","journal-title":"Int J Tuberc Lung dis"},{"key":"3714_CR31","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1016\/j.vaccine.2008.08.006","volume":"26","author":"Z Araujo","year":"2008","unstructured":"Araujo Z, de Waard JH, de Larrea CF, Borges R, Convit J (2008) The effect of Bacille Calmette-Guerin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis. Vaccine 26:5575\u20135581","journal-title":"Vaccine"},{"key":"3714_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","volume":"12","author":"MX Rangaka","year":"2012","unstructured":"Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, Mwansa-Kambafwile J et al (2012) Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect dis 12:45\u201355","journal-title":"Lancet Infect dis"},{"key":"3714_CR33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/annrheumdis-2011-200489","volume":"71","author":"DY Chen","year":"2012","unstructured":"Chen DY, Shen GH, Chen YM, Chen HH, Hsieh CW, Lan JL (2012) Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFalpha inhibitors: the utility of IFNgamma assay. Ann Rheum dis 71:231\u2013237","journal-title":"Ann Rheum dis"},{"key":"3714_CR34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/acr.21788","volume":"65","author":"EC Hsia","year":"2013","unstructured":"Hsia EC, Cush JJ, Matteson EL, Beutler A, Doyle MK, Hsu B et al (2013) Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in phase III clinical trials. Arthritis Care res (Hoboken ) 65:309\u2013313","journal-title":"Arthritis Care res (Hoboken )"},{"key":"3714_CR35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-147-10-200711200-00006","volume":"147","author":"A Raval","year":"2007","unstructured":"Raval A, Akhavan-Toyserkani G, Brinker A, Avigan M (2007) Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab. Ann Intern med 147:699\u2013702","journal-title":"Ann Intern med"},{"key":"3714_CR36","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/art.21734","volume":"54","author":"R Westhovens","year":"2006","unstructured":"Westhovens R, Yocum D, Han J, Berman A, Strusberg I, Geusens P et al (2006) The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial. Arthritis Rheum 54:1075\u20131086","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3714-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3714-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3714-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T13:02:06Z","timestamp":1569416526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3714-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,6]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3714"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3714-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,6]]}}}